首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Frontiers in oncology

缩写:FRONT ONCOL

ISSN:2234-943X

e-ISSN:2234-943X

IF/分区:3.3/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引33633
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Linqian Song,Jian-Guo Zhou,Hu Ma Linqian Song
Non-small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer and remains the leading cause of cancer mortality globally. The lack of early diagnostic tools and effective therapeutic targets contributes to poor outcomes f...
Xiaoyu Zhi,Lehui Du,YaNan Han et al. Xiaoyu Zhi et al.
Radiotherapy is a major source of ionizing radiation that adversely affects the male reproductive system. FLASH radiotherapy (FLASH-RT), a novel technique delivering ultra-high dose rate (UHDR) radiation, has shown promise in reducing norma...
Bingchen Li Bingchen Li
Thoracic radiotherapy is a primary treatment modality for lung cancer, with approximately two-thirds of patients receiving it. The association between heart dose and post-radiotherapy survival and cardiac injury represents a critical area o...
Zhendong Shi,Xiaoxing Bian,Hanyan Zhu et al. Zhendong Shi et al.
Purpose: In this study, we aimed to determine the diagnostic performance of MRI in assessing neoadjuvant therapy (NAT) response, investigate determinants of its accuracy, and develop a nomogram for predicting pathological...
Janine Grüninger,Saskia Lehr,Frank Meiss et al. Janine Grüninger et al.
Immune checkpoint inhibitors (ICIs) targeting PD-1, PD-L1 and CTLA-4 have transformed the treatment of malignant melanoma, significantly improving patient survival rates. However, these therapies often result in immune-related adverse event...
Rong Wu,Qiuling Shi,Dongbiao Liao et al. Rong Wu et al.
Background: Although antiangiogenic agents and HIFU (High-intensity focused ultrasound) are extensively used in the systematic treatment of advanced primary and secondary liver cancer, respectively, the efficacy and safet...
Xuan-Hao Pan,Nan Wang,Yi-Chun He et al. Xuan-Hao Pan et al.
Background: Glioblastoma (GBM) is one of the most aggressive neurogenic tumors. Despite advances in treatment, the presence of the blood-brain barrier (BBB) continues to pose significant challenges to effective therapeuti...
Na Wei,Shifeng Bai,Donghui Kong et al. Na Wei et al.
Endometrial carcinosarcoma is a rare, aggressive uterine malignancy, usually affecting postmenopausal women with recognised risk factors such as prolonged unopposed oestrogen exposure, tamoxifen use, pelvic irradiation, or high BMI. We repo...